Introduction
The cAMP pathway plays a central role in the response to hormonal signals for cell proliferation, differentiation and apoptosis (reviewed in Taylor et al., 1990; McKnight, 1991; Spaulding, 1993; Francis and Corbin, 1994; Gjerstsen and Doskeland, 1996) . Apoptosis is a physiological mechanism which can be triggered by external signals or programmed by the cell itself (Wyllie et al., 1980; Potten, 1988; Wyllie, 1993; Williams and Smith, 1993; Steller, 1995; White, 1996) . Exogenous stimuli which activate speci®c receptors (reviewed in Nagata and Golstein, 1995) , or removal of growth factors, as in the case of hematopoietic progenitor cells (Williams et al., 1990) , all induce apoptosis. Apoptosis can also be arti®cially induced by treatment with hormones or chemotherapeutic drugs (Fisher, 1994; Thompson, 1995) . Signal transduction pathways appear to play a key role in apoptosis. The second messengers Ca 2+ , cAMP and phorbol esters which activate protein kinases such as calmodulin kinase, PKA, PKC and also tyrosine kinases (Pratt and Martin, 1975; Kizaki et al., 1989 Kizaki et al., , 1990 McConkey et al., 1990; Susuki et al., 1990; Lanotte et al., 1991; Dowd and Miesfeld, 1992) have all been implicated in apoptotic processes. The mechanisms whereby signalling pathways direct apoptosis appear to be complex and cell type-speci®c. Indeed, cAMP induces apoptosis in thymocytes McConkey et al., 1992; Susuki et al., 1990) , while it stimulates proliferation of epithelial cells and neuronal cell dierentiation (Freidman, 1976; Dumont et al., 1989) . Importantly, cAMP synergises with glucocorticoids and PKC signalling in inducing apoptosis (McConkey et al., 1990; Susuki et al., 1990; Groul and Altschmeid, 1993; reviewed in McConkey et al., 1992) , while it cooperates with retinoids in the dierentiation of teratocarcinoma cells (Hu and Gudas, 1990; WeilerGuetter et al., 1992) and of various leukaemia cells (Olsson et al., 1982; Gianni et al., 1995; Ruchaud et al., 1994) .
The diversity of action of cAMP signalling in the hemopoietic system, particularly the capacity of cAMP to modulate hemopoietic cell development has been known for more than a decade. cAMP-elevating agents exert negative and positive control on proliferation and dierentiation of murine and human myeloid, lymphoid and erythroid progenitor cells (Rossi et al., 1980; Taetle and Koessler, 1980; . cAMP induces monocytic dierentiation of M1 mouse myeloid leukaemia (Homma et al., 1978) and of a subclone of HL60 cells (Tortora et al., 1988) . It potentiates granulocytic dierentiation of retinoidinduced maturation of human myeloid leukaemia cells (Olsson et al., 1982; Ruchaud et al., 1994) . cAMP signalling triggers apoptosis in normal and leukaemic thymocytes and in myeloid leukaemia cells. The IPC-81 cell line , derived from a rat myeloid leukaemia so far represents one of the bestde®ned cell systems to study cAMP-induced apoptosis. We have previously demonstrated that treatment with agents elevating intracellular cAMP levels (cholera toxin, prostaglandins (PGEs), IBMX and cAMPanalogues) rapidly induces IPC-81 cell death (Lanotte et al., 1991) . More than 90% of the cells show morphological changes and internucleosomal DNA fragmentation typical of apoptosis within 6 h of induction. Furthermore, speci®c 28S ribosomal RNA cleavage has recently been identi®ed as a typical characteristic of apoptosis in these cells (Houge et al., 1993 (Houge et al., , 1995 . It has been established that cAMP induced apoptosis of IPC-81 cells is mediated by isoform I of the PKA holoenzyme. Indeed, a subclone derived from IPC-81 cells (IPC-RI D336 ) carrying a point mutation in the RIa regulatory subunit at the cAMP binding site is resistant to cAMP induced apoptosis (Duprez et al., 1993) . Intracytoplasmic microinjection of puri®ed PKA catalytic subunit commits the cells to death (Vintermyr et al., 1993) . Furthermore, cell death is delayed by treating IPC-81 cells with actinomycin D or cycloheximide. This treatment suppresses morphological changes typical of apoptosis, as well as DNA fragmentation and 28S rRNA cleavage (Lanotte et al., 1991; Houge et al., 1993 Houge et al., , 1995 . This suggest a direct involvement of PKA-directed gene expression. Here we have analysed whether a speci®c nuclear response to cAMP exists during apoptosis in hemopoietic cells.
cAMP-activated PKA phosphorylates speci®c nuclear transcription factors which include CREB, CREM and ATF-1 (Sassone-Corsi, 1994). These factors bind as dimers to the speci®c consensus sequence TGACGT-CA, CRE (cAMP responsive element) (Montminy et al., 1986 ). CREM appears to play a privileged role amongst CRE regulatory factors in a variety of dierent physiological systems. By a process of extensive alternative splicing, the CREM gene generates a family of both activator and repressor isoforms (Delmas et al., 1992; Foulkes et al., 1991 , 1992a ,b, Laiode et al., 1993 . Using an alternative intronic promoter the CREM gene also generates the powerful repressor, ICER Stehle et al., 1993) . The ICER speci®c promoter (P2) contains tandemly repeated CRE-like elements and is rapidly and strongly induced upon activation of the cAMP pathway. The kinetics of cAMP induction place ICER as a key player in the early cellular response to hormonal stimuli. It has been shown that ICER is predominantly expressed in neuroendocrine tissues Stehle et al., 1993; Monaco et al., 1995; Lalli and Sassone-Corsi, 1995) .
Here we show that ICER is rapidly induced by prostaglandin E1 and cAMP treatment of the IPC-81 leukaemic cell line and that CREM activation directly participates in the decision of the cell to dierentiate or die. Transfection experiments show that ICER acts as a repressor of cAMP-induced apoptosis.
Results and Discussion

Prostaglandin treatment induces apoptosis of IPC-81 cells
We have previously shown that agonistic stimulation of adenylate cyclase coupled membrane receptors or treatment with cholera toxin and cAMP analogues induce IPC-81 cells to undergo apoptosis (Lanotte et al., 1991) .
Prostaglandins have a crucial role in the physiological regulation of lymphoid and myeloid cell development (Taetele and Koessler, 1980; Hayari et al., 1985; Monaco et al., 1995) . Prostaglandin E1 (PGE 1 ) treatment of IPC-81 cells causes a dramatic morphological change which is reminiscent of cAMPinduced cell death ( Figure 1a,b) ; and in Lanotte et al., 1991) . Cells treated with PGE1 show high sensitivity with an IC 50 of 0.2 mM (Figure 1c ). PGE 1 also causes DNA fragmentation (Figure 1d lower panel) typical of apoptosis as described in other cells (Duke et al., 1983; McConkey et al., 1990) .
Prostaglandin E have been shown to activate signalling pathways coupled to adenylate cyclase (Hittleman and Butcher, 1973; Sonnenburg and Smith, 1988; Mori et al., 1989) and phosphorylation by PKA. Therefore, we wanted to know whether PGE1 also mediated a cAMP-dependent nuclear response. We tested whether CREM gene expression may be modulated in IPC-81 cells by PGE 1 . In Figure 1d we show that CREM mRNA levels are dramatically induced, reaching a peak by 2 ± 3 h after PGE 1 treatment and decreasing by 6 ± 8 h, accompanying apoptosis, as shown by DNA fragmentation.
CREM induction in IPC-81 cells upon apoptosis
To mimic the transduction of an external signal where cAMP is the second messenger, we used analogs of this molecule which directly stimulate PKA. Here we have used 8CPT-cAMP because of its lipophilicity, anity for the R1 subunit of PKA and stability (Braumann and Jarstor, 1995; Ruchaud et al., 1995) . In addition, 8CPT-cAMP was shown to eciently induce apoptosis in IPC-81 cells (Ruchaud et al., 1995) .
The level of Cyclic-AMP Responsive Element Binding (CREB) mRNA is aected by cAMP treatment since a marked decrease occurs at 90 min after treatment (Figure 2 ). The decrease in CREB mRNA expression correlates with the onset of apoptosis indicated by the 28S rRNA cleavage (Houge et al., 1993 (Houge et al., , 1995 (see lower panel, lanes 13 and 14), and also follows a marked decrease in b-actin RNA which accompanies apoptosis (lane 14). In contrast, CREM mRNA expression (Figure 2 ) is undetectable in untreated cells (lane 7), but is then strongly induced as early as 30 min after cAMPtreatment, to then peak after 2 ± 3 h (lanes 12 and 13). The strong CREM mRNA upregulation persisted until 4 h after treatment. Importantly, the induction of CREM occurred in a dose-dependent manner (lanes 1 ± 6). Similar to cell viability in culture which shows a -all or non-response (Lanotte et al., 1991 , Ruchaud et al., 1995 , CREM mRNA levels shifted from low to maximum levels when cAMP molarity increased from 24 mM to 50 mM. Thus, CREM inducibility shows a strict dose-dependent response. This feature is strikingly similar to the dose-dependent, cAMP-induced apoptosis (Lanotte et al., 1991) .
cAMP treatment results in the induction of various CREM transcripts, 2.5 kb, 1.8 kb and 1.5 kb (Figure 2 ). The CREM gene generates a family of activators and repressors by alternative splicing, translation initiation and use of an alternative intronic promoter (Delmas et al., 1992; Foulkes et al., 1992; Laoide et al., 1993; Molina et al., 1993) . In order to determine the type of CREM transcripts which are induced in IPC-81 cells we used RNAse protection analysis (Figure 3a . RNA from cAMP-treated IPC-81 cells protects two fragments (122 nt and 95 nt) which correspond to ICER isoforms generated from the P2 promoter using the S1 and S2 transcription start sites, respectively. The protected fragment corresponding to the CREMa,b,g or t transcripts (40 nt) derived from the P1 promoter reveals a very low and non-induced expression (not seen in Figure 3b ; detectable only after a prolonged exposure). Western blot analysis of IPC-81 cellular extracts with an anti-CREM antibody shows ( Figure 4 ) that ICER proteins are detected as trace amounts in untreated cultures (see in Figure 4 and legend; panel a overexposed to show ICER expression). cAMP treatment resulted in the induction of ICER protein corresponding to a doublet migrating around 16 ± 18 kDa and a major 13 kDa band. When the cells are treated with cAMP for 2 h the proteins are upregulated, then strongly expressed after 3 h ( Figure 4a ). All three ICER bands are upregulated by cAMP in a dosedependent manner. These protein bands show a similar increase, irrespective of their distinct initial levels. ICER proteins persisted at very high levels until apoptosis was observed (4 ± 6 h). The kinetics of induction of ICER proteins are consistent with those of the ICER transcript ( Figure 2 ) and with the kinetics of induction of apoptosis by cAMP (not shown). Since ICER transcripts and ICER proteins are the only CREM gene products found upregulated by cAMP in IPC cells, it will then be referred to ICER only, in the following sections of this paper.
cAMP triggers both induction and repression of apoptosis
The block of protein synthesis by cycloheximide (CHX) during the early phase of cAMP-induction confers resistance to cAMP-induced cell death, as shown by inhibition of DNA fragmentation (Lanotte et al., 1991) , 28S rRNA cleavage (Houge et al., 1993 (Houge et al., , 1995  and in this paper, Figure 5a (lower panel), compare lanes 4 ± 6 (without CHX) and lanes 9 ± 11 (with CHX). In these experiments CHX treatment alone is not inducing rRNA cleavage (Figure 5a Figure 5c , after 3 h). The biphasic nature of the CHX-response curve (Figure 5c ) is consistent with the notion that the cells synthesise an early eector to trigger cell death. The synergistic eect of CHX allows us to hypothetise that a distinct component may be produced to counteract cAMPinduced cell death, and that the synthesis of this component is also inhibited by CHX treatment (after 3 h). Accordingly, in IPC-81 cells the eector of apoptosis is generated before the gene product which counteracts cell death, and the balance between the expression of the inducer and the repressor may determine the cell fate.
ICER expression and cell fate
The IPC-RI D336 mutant cells carry a mutation in the RIa cAMP binding site of PKA (see in Duprez et al., Eects of CHX treatments on cell viability, rRNA cleavage and ICER induction. (a) Eect of CHX and cAMP on ICER induction and 28S rRNA cleavage. Lane 1, untreated culture; lanes 2 ± 6, 8-CPT-cAMP treatment (100 mM); lanes 7 ± 11, combined treatment of 8-CPT-cAMP (100 mM) and CHX (28 mg/ml); lanes 12 ± 15, CHX treatments (28 mg/ml). Notice that CHX alone is not inducing apoptosis at this concentration. (b) Eect of CHX and cAMP on IPC-81 cell viability. Cells (10 5 cell/ml) were cultured in 24 well culture plates for 0 to 8 h with either 8-CPT-cAMP alone, CHX alone, or with 8CPT-cAMP plus CHX (& 8CPT-cAMP alone (100 mM); * CHX alone (28 mg/ml); & 8CPT-cAMP (100 mM) plus CHX (28 mg/ml)). Apoptosis was evaluated by morphological analysis of at least 500 cells on MGG stained slides. (c) Eect of delayed treatments with CHX on cAMP-induced apoptosis. CHX was added in cultures at dierent times after the induction of apoptosis by 8CPT-cAMP (100 mM) and cell viability was measured, 8 h after cAMP induction, in all cultures (*). Cell viability was also measured in cultures when CHX alone was added at the same times (~). C1 shows the cell viability in untreated cultures; C2 shows the cell viability in cultures treated with cAMP alone. Values below the C2 line indicate the protective eects on CHX when delivered during the early phase of apoptosis induction; values above C2 show the synergistic eect of cAMP and CHX on apoptosis, when CHX is delivered only during the late phase of apoptosis Transcription repressor ICER and cAMP-induced apoptosis S Ruchaud et al 1993). In these cells, the CREM gene is only weakly upregulated at the highest concentrations of 8CPT-cAMP (1000 mM), as shown by ICER mRNA levels ( Figure 6a , lanes 10 ± 12. These cells also show a remarkable resistance to cAMP-induced cell death (Figure 6b, lanes 9 ± 15) , as demonstrated by a lack of DNA fragmentation. This strengthens the correlation between a strong ICER upregulation and cell death. However, the lack of CREM gene inducibility in the mutant IPC-81 cells resistant to apoptosis does not indicate what role ICER could play in the control of cell death.
As shown above, ICER is consistently strongly upregulated in IPC-81 cells at cAMP concentrations which trigger cell death. We wanted to analyse the response of cells to the lowest cAMP concentration able to induce a signi®cant ICER upregulation. When cells were treated with 20 ± 30 mM 8-CPT-cAMP they responded to cAMP by a slight ICER upregulation (for instance, such an experimental condition is featured in Figure 2 , lane 4) and most cells showed only little morphological alteration after 8 h, but as few as 20% of the cells were found viable after 48 h. These surviving cells are all growth arrested (no mitosis were found, not shown) and clearly show morphological signs of maturation (Figure 7) .
We have shown that a gradation in the strength of cAMP signal which can be obtained with either the RIa mutation in IPC-RI D336 (Duprez et al., 1993) or with a gradual increase in the concentration of a stable cAMP-analogue in the culture can change the fate of IPC-81 cells. When ICER is not induced, no detectable cell response is observed. When a low expression of ICER is observed, cells either undergo apoptosis (after 8 h) or embark in cell dierentiation (48 h). When a powerful signal is delivered (PGE 1 25 mM) or 8-CPTcAMP (200 mM)) it causes a strong and sustained ICER expression, accompanied in a few hours by massive death of immature cells, with all the features of programmed cell death.
Programmed cell death is classically divided into distinct phases, the transduction of a death signal by intracellular signalling pathways (signalling), the cascade of (positive and negative) regulation which results in cell death triggering, then ®nally an irreversible process of cell destruction (execution) (see in recent reviews by Homan and Lieberman, 1994; Steller, 1995; Martin and Green, 1995; White, 1996; Rowan and Fischer, 1997 To be ecient the transcriptional repression of the death signal by ICER has to occur before selfdestruction had started. An indication of the action of ICER as a repressor is shown by its eects on its own transcription. As shown, ICER downregulation (repression) does not occur before 4 ± 6 h, while cAMP-induced cell death becomes rapidly irreversible because of self destruction has started earlier (3 h). As a matter of fact, our results support the hypothesis that ICER neither represses its own expression, nor the cell death programme, before death signalling has progressed beyond transcriptional regulation and apoptosis has been triggered.
A constitutive expression of ICER protects IPC-81 cells against cAMP-induced programmed cell death
IPC-81 cells were transfected by electroporation of the MSCVpkg expression vector constructs containing the ICERIIg coding sequence (ICER-S) under the control of the MSCV promoter. As experimental controls, a similar expression vector with a ICER anti-sense (AS) insert or an`empty vector' were also used to transfect cells. Several cell lines were selected for puromycin resistance and tested for exogenous ICER-S and AS mRNA expression.`Empty vector' transfectants (puromycin-resistant controls) had unchanged ICER expression and responses to cAMP compared to nontransfected control cells. In ICER-AS transfectants constitutively expressing antisense mRNA, as measured by Northern blot analysis (not shown), there was no modi®cation in the cAMP-induced expression of ICER protein suggesting that in these cells ICER-AS mRNA did not interfere speci®cally with ICER translation. Furthermore, these transfectants were not altered in their apoptotic response to cAMP (not shown). ICER-S clones show a strong constitutive expression of a 4.5 Kb ICER mRNA transcript derived from the MSCV construct (Figure 8a ). In these ICER-S transfected cells the endogenous 2.5 kb, 1.8 kb and 1.5 kb CREM transcripts are no longer inducible by cAMP (Figure 8a , compare lanes 4 and 5 and lanes 11 and 12) while CREM induction in thè empty vector' transfectants remains similar to that observed in IPC-81 cells (Figure 2) . In addition the clones show constitutive expression of a 13 kDa ICER protein by Western blot analysis using anti-CREM antibody (Figure 8b ). The 18 kDa ICER doublet remained at the basal expression level in ICER-S transfected cells, while it is upregulated in the puromycin-resistant control cells con®rming that exogenous ICER repressed both the expression of endogenous ICER mRNA transcripts and protein.
Morphological analysis and viability assay indicate that ICER-S transfected cells are resistant to cAMPinduced apoptosis. However, a tenfold increase in the cAMP concentration can still trigger cell death: the IC50 (35 mM for the puromycin resistant controls) is shifted to 400 mM for ICER-S transfectants ( Figure  8c ). cAMP (200 mM) induces no signi®cant changes in the cell morphology of the transfected cells. Although growth arrest is observed, no granulocytic maturation comparable to that observed at low cAMP concentrations occurred. This demonstrates that ICER functions as a repressor of cAMP-induced programmed cell death.
Conclusion
Here we document for the ®rst time cAMP inducibility of the CREM gene in a myeloid leukaemia cell line. The induced CREM isoform corresponds to the powerful transcriptional repressor ICER, indicating that down-regulation of the CRE-containing genes is likely to follow this induction. A strong ICER induction accompanies apoptosis triggered by treatment with the prostaglandin E1 or by cAMP analogs. However, at low cAMP concentrations ICER is only slightly expressed and a variable number of IPC-81 cells, not triggered to apoptosis, embark on granulocytic cell maturation. That ICER failed to block cAMP-induced apoptosis could be due to the fact that CRE-containing immediate early genes which trigger apoptosis are not repressed by ICER because its expression is too low or occurs too late. This hypothesis is supported by the action of CHX and the features of ICER transfectants expressing constitutively ICER. A strong expression of ICER in these transfected cells, before cAMP-triggering, can block the upregulation of the endogenous CREM transcripts and also block cAMP-induced apoptosis. The eects of ICER on cell fate remain dicult to elucidate when expressed at low level, both using the inducible IPC-81 cells, or the transfected clones constitutively expressing ICER. We cannot exclude that ICER acts as an inducer of cell death (repression of survival (anti-apoptotic) genes), and as a repressor of apoptosis (repressor of genes essential in the apoptotic machinery), depending on whether it is expressed at low or high levels. For this reason, the development of an inducible system, where ICER expression is precisely tuned, is now required. Altogether our data suggest that the fate of the cells ± granulocytic maturation and apoptosis ± is determined by both the intensity of the cAMP-signal and the capacity of these cells to rapidly counteract this signal by inducing ICER. These ®ndings represent an important step in the understanding of the physiological processes linked to the regulation of the CREM gene. Namely, they extend the property of CREM inducibility to the nonneuroendocrine cells. Also, it is the ®rst time that CREM activation is linked to the decision of a cell to dierentiate or to die. Thus, CREM participates in the complex regulatory mechanisms by which signalling pathways modulate cell fate.
Signal-induced cell death is modulated essentially at two distinct levels, by acting on the signal transduction machinery ± on the expression or the function of its eector components ± or by acting on the triggering of apoptosis which depends upon the action of positive and negative regulators (Homan and Lieberman, 1994; Steller, 1995) . The action of CHX on cAMPinduced cell death in IPC-81 cells served to precisely demarcate a narrow window of time during which the transcriptional machinery is required to trigger apoptosis. An interesting feature of CHX action in these cells is an early blockade of cell death, then a late synergy between CHX and cAMP in inducing cell death, suggesting that cAMP induces sequentially the inducer of apoptosis and a repressor. The transfection experiments have permitted to identify ICER as a repressor of cAMP-induced cell death. It remains to elucidate whether ICER acts only by repressing the cAMP-signalling or also by repressing some CREcontaining genes playing important roles as inducers of cell death. Identi®cation of the gene regulatory targets of ICER in hemopoietic cells should thereby shed light on the basic molecular mechanisms underlying cell fate decision.
Materials and methods
Cell culture and cell viability assay
The rat promyelocytic leukaemia cell line IPC-81 was cultured as previously described (Lanotte et al., 1991) . The IPC-RI D336 cAMP-resistant clone was isolated as described by Duprez et al. (1993) . Cell morphology was analysed using the May ± GruÈ nwald-Giemsa staining. Cell viability was assessed by morphological integrity of cells under phase-contrast microscopy and by the dimethylthiazoldiphenyl tetrazolium bromide colorimetric assay (MTT) for mitochondrial dehydrogenase enzymatic activity (Mosmann, 1983) or WST-1 assay (Boehringer Mannheim).
DNA fragmentation
Cells in exponential phase of growth were pelleted and immediately disrupted in lysis buer (10 mM Tris-HCl pH 8, 100 mM EDTA, 10 mM EGTA, 0.5% SDS), according to a protocol adapted from (Williams, 1987) . DNAse-free RNAse (Sigma) was added to 20 mg/ml of lysate, which was incubated for 2 h at 378C. The cell lysates were then incubated at 568C with proteinase K (Sigma) at 100 mg/ml for 1 h. The DNA was extracted with phenol, pelleted with 2 vol. ethanol and 0.1 vol. 10 M ammonium acetate, dissolved in TE-buer (10 mM Tris-HCl pH 8, 1 mM EDTA) and separated on a 1.5% agarose gel (FMC bioproducts, USA). DNA fragments were visualised on gels after ethidium bromide staining.
Isolation of RNA and Northern blot analysis Total RNA was isolated according to the procedure described by Chomczynsky and Sacchi (1987) . 20 mg of total RNA were electrophoresed in a 1.1% agarose/10% formaldehyde gel and then blotted on a nylon membrane. 28S rRNA cleavage was shown by ethidium bromide staining of total RNA as previously described (Houge et al., 1995) .
RNAse protection analysis RNA probes, labelled with [a-32 P]UTP, were prepared using reagents from a riboprobe kit (Promega). These probes were used for RNAse protection studies, following a standard protocol previously described (Ausubel et al., 1987) .
Western blot analysis of protein expression Cultured cells were washed in PBS and pelleted by centrifugation at 400 g for 5 min. Pellets of 5610 5 cells were immediately lysed by adding 100 ml of a boiling Laemmli solution containing b-mercaptoethanol and disrupted with a pestle. Samples were then boiled for 5 min and insoluble material removed by centrifugation at 13 000 g for 5 min. Proteins were quanti®ed by a Coomasie colorimetric titration. Protein extracts (30 mg) were loaded on 15% SDS-polyacrylamide gel, electrophoresed, and blotted onto nitrocellulose membranes (Schleicher & Schuell, Germany) . After transfer to the nitrocellulose membrane, proteins were visualised with Ponceau S (Sigma) to con®rm equal loading of protein. Membranes were blocked with 5% unfatted milk in PBS pH 7.6, 137 mM NaCl, then incubated with a speci®c rabbit polyclonal antiserum (dil: 1/100) raised against recombinant CREMt protein (Delmas et al., 1993) in PBS/3% milk for 18 h at 48C. Membranes were incubated with horseradish peroxidase-linked protein A (Amersham) for 30 min at 258C. Each of these steps were followed by three washes for 10 min in PBS/3% milk. Labelling was performed as described in the ECL protocol (Amersham).
Plasmids, cell transfection, selection of ICER-transfected IPC-81 cells The MSCVpkgICERIIgS and AS vectors were obtained by inserting the complete ICER IIg rat cDNA sequence in sense and antisense position respectively into the EcoRI restriction site of a MSCVpkg vector containing a puromycin resistance gene (Hawley et al., 1994 ; generously given by Dr O Bruland, Bergen, NO). The constructs, MSCVpkgICERIIgS and AS and MSCVpkg as control (each 2 mg) were linearized with Sca I and used to electroporate 2610 6 IPC-81 cells (25 mF; 600 V on a BIORAD gene pulser system). Selection of stable transfected clones was performed by maintaining the culture at a 0.8 mg/ml puromycin concentration during six weeks. After ampli®cation of surviving cells, proteins and RNA were extracted and analysed on Northern and Western blots.
